Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

NCT01358357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

965

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Lurasidone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.